Skip to main content

BLTE · Belite Bio, Inc · Holdings

Track BLTE — free
$150.27 -2.91 (-1.90%)
Market Cap
$6.05B
Shares
40.27M
Volume · Oct 22 125.66K Avg daily vol (3M) 183.42K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 80
Total Value: $1,458,813,361
Total Shares: 9,473,546

Institutional Ownership Trend

18 quarters

Holder Concentration

Across 80 13F filers
Top Holder
32.5%
Sep 2023 → Jun 2026 · range 23.2% – 79.3%
of institutional value
Top 5
62.5%
Sep 2023 → Jun 2026 · range 62.5% – 99.5%
of institutional value
Top 10
78.1%
Sep 2023 → Jun 2026 · range 78.1% – 100.0%
of institutional value
HHI
1,404
Sep 2023 → Jun 2026 · range 1,255 – 6,401
Broadly held

Who Holds BLTE

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 80 filers, like-for-like change +3.9%; actively managed books +2.9%; index-like books +30.1%.

Holder type Share Filers Change
Registered adviser 52.4% 44 +12.8%
Exempt adviser 32.7% 5 +1.1%
Adviser 1.5% 2 +38.2%
Bank 4.5% 9 -47.6%
Non-US 0.0% 2 -56.8%
Holding company 4.3% 3 +30.0%
Unknown 4.6% 15 +3.4%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

80 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
5
6.25% of filers hold it in their top 10
Mar 31, 2026: 5
Holders above 5%
1
median weight 0.008%
Mar 31, 2026: 2
Crowding
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Top 10 holders
78.1%
of 13F shares, Herfindahl 0.140
Active holders
+2.9%
like-for-like share change of active filers
5% stakes on record
2
0 13D, 2 13G (0 institutional, 1 passive, 1 exempt)
How long holders have held it value-weighted 3.6 quarters
Under 1 year 71.7% 1 to 3 years 24.1% 3 years or more 4.21% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $1,024,441 (0 buying, 1 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$134.88
estimated per share
Mar 31, 2026: $133.63
Quarter-end price
$153.98
implied by 13F values
Estimated gain or loss
+14.2%
price against the estimated cost
Estimated at a loss
26.6%
of costed 13F value

Estimated cost covers 99.9% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies BLTE's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 DNTH Dianthus Therapeutics, Inc. 10
2 TNGX Tango Therapeutics, Inc. 9
3 ERAS Erasca, Inc. 8
4 CGEM Cullinan Therapeutics, Inc. 6
5 RVMD Revolution Medicines, Inc. 15
6 IMVT Immunovant, Inc. 6
7 GPCR Structure Therapeutics Inc. 8
8 ELVN Enliven Therapeutics, Inc. 8
9 PRAX Praxis Precision Medicines, Inc. 8
10 SYRE Spyre Therapeutics, Inc. 8

Shareholder Targets

13F filers that own its peers but not BLTE, quarter ended Jun 30, 2026

Found through its holder-overlap peers: DNTH, TNGX, ERAS, CGEM, RVMD, IMVT, GPCR, ELVN, PRAX, SYRE, ABVX, INSM, ORKA, XENE, TYRA, CGON, MLYS, JBIO, TARS, EWTX. 1,123 filers in all.

# Filer In peers
1 BlackRock, Inc. Holding company, Index-like $9,673,626,023 20 held
2 Jupiter Topco LLC Unknown, Diversified active $5,445,219,160 20 held
3 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $5,296,769,876 18 held
4 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $4,294,062,093 12 held
5 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $4,104,994,967 18 held
6 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $3,161,496,464 4 held
7 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $2,224,893,935 20 held
8 TCG Crossover Management, LLC Unknown, Diversified active $2,024,211,248 9 held
9 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $1,917,251,761 11 held
10 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $1,645,138,132 9 held

Fund Ownership of BLTE by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.09% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.04% 15,214
Index ETFs 0.05% 21,210
Active ETFs 0.00% 1,282
Active funds 0.54% 219,187
Unclassified 0.01% 3,815
All registered funds 0.65% 260,708
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 80 of 80
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1889109 CUSIP 07782B104 13F (30d) 5 filings 5 filers Visit website Investor relations